
1.49BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0015285941
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
4.21
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.99
Wall Street Target Price
18.78
EPS Estimate Current Year
-1.91
EPS Estimate Next Year
-1.89
EPS Estimate Current Quarter
-0.4386
EPS Estimate Next Quarter
-0.4619
Most Recent Quarter
-
Revenue TTM
48,266,000
Gross Profit TTM
-135,566,000
EBITDA
-172,875,008
Profit Margin
0.00%
Return On Assets TTM
-18.08%
Return On Equity TTM
-37.10%
Revenue Per Share TTM
0.394
Qtly Revenue Growth YOY
-64.90%
Diluted Eps TTM
-1.99
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
30.0723
Price Book MRQ
2.7391
Enterprise Value Revenue
21
Enterprise Value EBITDA
6
283.89
3.04%136.01
1.42%17.40
0.75%294.30
0.33%803.19
0.00%630.30
-11.57%434.31
-3.61%797.77
-2.91%147.30
-1.49%68.51
-0.71%